These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15640786)

  • 1. Molecular imaging and targeted therapy: on creativity, research and visionary spirits.
    Lucignani G; Mather SJ
    Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):245-7. PubMed ID: 15640786
    [No Abstract]   [Full Text] [Related]  

  • 2. A pragmatic perspective on molecular targeted radionuclide therapy.
    Larson SM; Krenning EP
    J Nucl Med; 2005 Jan; 46 Suppl 1():1S-3S. PubMed ID: 15653645
    [No Abstract]   [Full Text] [Related]  

  • 3. JNM supplement on molecular radiotherapy.
    Wong CO; Pandit-Taskar N; Larson SM
    J Nucl Med; 2005 Oct; 46(10):1765-6; author reply 1766. PubMed ID: 16204728
    [No Abstract]   [Full Text] [Related]  

  • 4. The immune system and cancer: the evolving role of molecular imaging and molecular targeted therapy.
    Lucignani G
    Eur J Nucl Med Mol Imaging; 2006 Apr; 33(4):503-5. PubMed ID: 16596377
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecules, mechanisms, and momentum in bone and cartilage research.
    Zaidi M; Iqbal J; Sun L; Blair HC
    Biochem Biophys Res Commun; 2005 Mar; 328(3):647-50. PubMed ID: 15694397
    [No Abstract]   [Full Text] [Related]  

  • 6. All systems go!
    Nat Cell Biol; 2006 Nov; 8(11):1179. PubMed ID: 17077850
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjuvant and combined radioimmunotherapy: problems and prospects on the road to Minerva.
    Goldenberg DM
    J Nucl Med; 2006 Nov; 47(11):1746-8. PubMed ID: 17079805
    [No Abstract]   [Full Text] [Related]  

  • 8. Iberia: from fable to the bench.
    Casares F
    Int J Dev Biol; 2009; 53(8-10):1269-71. PubMed ID: 19938322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The T complex of the mouse: a failure rich with instruction].
    Morange M
    Rev Hist Sci Paris; 2000; 53(3-4):521-54. PubMed ID: 19119521
    [No Abstract]   [Full Text] [Related]  

  • 10. Bridging the culture gap.
    Knight J
    Nature; 2002 Sep; 419(6904):244-6. PubMed ID: 12239534
    [No Abstract]   [Full Text] [Related]  

  • 11. Radioimmunotherapy. Progress, potential and problems.
    Mather SJ; Britton KE
    Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):248-50. PubMed ID: 15640787
    [No Abstract]   [Full Text] [Related]  

  • 12. Current status of therapy of solid tumors.
    Jhanwar YS; Divgi C
    J Nucl Med; 2005 Jan; 46 Suppl 1():141S-50S. PubMed ID: 15653662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunotherapy of solid tumors: the promise of pretargeting strategies using bispecific antibodies and radiolabeled haptens.
    Reilly RM
    J Nucl Med; 2006 Feb; 47(2):196-9. PubMed ID: 16455623
    [No Abstract]   [Full Text] [Related]  

  • 14. The promise of targeted {alpha}-particle therapy.
    Mulford DA; Scheinberg DA; Jurcic JG
    J Nucl Med; 2005 Jan; 46 Suppl 1():199S-204S. PubMed ID: 15653670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Research in the frontline. Consequences for hospital function and hospital structure].
    Eriksson H
    Nord Med; 1996 Feb; 111(2):35-9. PubMed ID: 8857082
    [No Abstract]   [Full Text] [Related]  

  • 16. Systemic targeted radionuclide therapy: potential new areas.
    Wong JY
    Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S74-82. PubMed ID: 16979445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic Targeted Radionuclide Therapy symposium introduction.
    Meredith RF
    Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S7. PubMed ID: 16979444
    [No Abstract]   [Full Text] [Related]  

  • 18. Technological advances in radioimmunotherapy.
    Dearling JL; Pedley RB
    Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):457-69. PubMed ID: 17537620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted alpha-particle therapy of microscopic disease: Providing a further rationale for clinical investigation.
    Zalutsky MR
    J Nucl Med; 2006 Aug; 47(8):1238-40. PubMed ID: 16882999
    [No Abstract]   [Full Text] [Related]  

  • 20. Perspectives on cancer therapy with radiolabeled monoclonal antibodies.
    Sharkey RM; Goldenberg DM
    J Nucl Med; 2005 Jan; 46 Suppl 1():115S-27S. PubMed ID: 15653660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.